Trials Offered by a Specific Doctor

DEPARTMENT OF DIGESTIVE & LIVER DISEASES
Investigator
Elizabeth Verna, MD
Email
ev77@cumc.columbia.edu

Dr. Elizabeth C. Verna manages patients with a variety of liver diseases. Her clinical interests focus on viral hepatitis and liver transplantation as well as the new emerging therapies for hepatitis C, liver cancer, alcoholic and non-alcoholic fatty liver disease and metabolic liver diseases. She also has expertise in the management of end stage liver disease and its complications.


Clinical Studies Managed By Dr. Verna:
More InfoTitleSponsorIRB Number
Details[CLOSED] Study for liver transplant recipients using drug (IgG) to prevent Hepatitis C virus (HCV) recurrenceBiotest Pharmaceuticals CorporationAAAL8001
Details[CLOSED] Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) using trial drugsMerck & Co. IncAAAL5200
Details[CLOSED] A study for liver transplant patients with Chronic HCV using study drug HarvoniGilead SciencesAAAO4208
Details[CLOSED] A study for patients with Chronic HCV Infection using study drugs Sofosbuvir, Velpatasvir and GS-9857GileadAAAQ4250
Details[CLOSED] A study for patients with Chronic HCV Infection using study drug combination Sofosbuvir/Velpatasvir/GS-9857GileadAAAQ4053
Details[CLOSED] A study for patients with Chronic Genotype 3 HCV Infection and Cirrhosis using study drugs Sofosbuvir, Velpatasvir and GS-9857Gilead Sciences, IncAAAQ4900
Details[CLOSED] A study for patients with Non-Alcoholic Steatohepatitis (NASH using study drug armacholGalmedAAAQ3206
Details[CLOSED] A study for patients with Chronic HCV Infection who have not received an NS5A Inhibitor using study drugs Sofosbuvir/Velpatasvir/GS-9857Gilead Sciences, IncAAAQ4901
Details[CLOSED] A study for patients with chronic hepatitis C and advanced heart failure or lung disease using study drug HarvoniGilead Sciences, IncAAAR0896
Details[CLOSED] Study of Emricasan in subjects with Non-Alcoholic Steatohepatitis (NASH) CirrhosisConatus Pharmaceuticals, Inc.AAAR5409
Details[CLOSED] GLIMMER: Study of Drug in Treatment of Pruritus (Itching) in Patients with Primary Biliary CholangitisGlaxoSmithKlineAAAR2207
DetailsA 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer)TARGET PharmaSolutions, Inc.AAAR3667
Details[CLOSED] TARGET-NASH: Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic SteatohepatitisTARGET PharmaSolutions, Inc.AAAR3890
Details[CLOSED] THE PRIORITIZE STUDY: Study of Oral Regimens for Hepatitis CUniversity of FloridaAAAQ8487
Details[CLOSED] Study of seladelpar in subjects with primary biliary cholangitis (PBC)CymaBay Therapeutics, Inc.AAAS1003
DetailsRegistry Study of Adult Patients with Primary Sclerosing Cholangitis (PSC)InternalAAAR9400
DetailsDiet in Primary Sclerosing Cholangitis (PSC)NAAAAS1777
DetailsPrevention of Hepatitis C with Antiviral HCV Therapy After Liver and/or Kidney TransplantUniversity of California, San FranciscoAAAR8005